Kwame Nkrumah University of Science and Technology
Also known as: Clinical Development Dept.,Kissei Pharmaceutical Co., Ltd. | Department of Community Health, School of Medical Science, Kwame Nkrumah University of Science & Technology | Department of Community Health, School of Medical Sciences, Kwame Nkrumah University of Science & Technology | Komfo Anokye Teaching Hospital | Komfo Anokye Teaching Hospital, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana | Kwame Nkrumah Univeristy of Science and Technolgy | Kwame Nkrumah University of Science and Technology | Kwame Nkrumah University of Science & Technology (KNUST) | Kwame Nkrumah University of Science & Technology, School of Medical Sciences, Ghana | Kwame Nkrumah University Teaching Hospital | Malaria Capacity Development Consortium-Ghana, Department of Community Health, School of Medical Science, Kwame Nkrumah University of Science and Technology | School of Medical Science (SMS), Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Jan 15, 2024
Timeline
1950s
- Jun 1, 1952
Kwame Nkrumah University of Science and Technology— Founded
Drugs by trial phase (28 distinct, 17 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
- doxycycline
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- klh-2109
- pneumococcal 13-valent conjugate vaccine
- silodosin
- yellow fever vaccine 17d strain
- measles-rubella vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- ints-gmma
- Inactivated polio virus - Enhanced
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (27)
- NCT06213506CollaboratorPhase 2Jan 15, 2024
- NCT04852185CollaboratorPhase 4Jul 5, 2021
- NCT02344628CollaboratorPhase 3Jun 1, 2015
- NCT02281643Lead sponsorPhase 2Oct 1, 2014
- NCT02281643Overall official - principal investigatorPhase 2Oct 1, 2014
- NCT02281643Study chairPhase 2Oct 1, 2014
- NCT02281643Reponsible party - principal investigatorPhase 2Oct 1, 2014
- NCT02118428Overall official - principal investigatorN/AMar 31, 2014
- NCT01659437CollaboratorPhase 2/Phase 3Dec 1, 2012
- NCT01659437Study directorPhase 2/Phase 3Dec 1, 2012
- NCT01651416Overall official - principal investigatorPhase 4Jul 1, 2012
- NCT01533532Study directorPhase 2Feb 12, 2012
- NCT02878265Study chairPhase 3Nov 1, 2011
- NCT02878265CollaboratorPhase 3Nov 1, 2011
- NCT01231113Reponsible party - principal investigatorPhase 3Jul 1, 2011
Details
- Founded
- Kumasi, GH Jun 1, 1952
- Last known activity
- Jan 15, 2024